Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB05350_nanopub.RAdwOxgzfOJX_rlDZ6WGBprt1gybviUEXXVrOz-O6cj7I#assertion>. }
Showing items 1 to 12 of
12
with 100 items per page.
- drugbank:DB05350 type drugbank_vocabulary:Drug assertion.
- drugbank:DB05350 label "AP-1034 [drugbank:DB05350]" assertion.
- drugbank:DB05350 seeAlso DB05350 assertion.
- drugbank:DB05350 description "AP-1034 utilizes Antares Pharma's proprietary advanced transdermal delivery (ATD(TM)) gel technology designed to allow delivery of active substances across the skin. The oxybutynin formulation is a cosmetic quality, clear and odorless gel designed to be rapidly absorbed through the skin following once-a-day application on the abdomen, shoulders or thighs." assertion.
- drugbank:DB05350 identifier "drugbank:DB05350" assertion.
- drugbank:DB05350 title "AP-1034" assertion.
- drugbank:DB05350 drugbank_vocabulary:x-cas cas: assertion.
- drugbank:DB05350 drugbank_vocabulary:drugbank-id "DB05350" assertion.
- drugbank:DB05350 bio2rdf_vocabulary:x-identifiers.org DB05350 assertion.
- drugbank:DB05350 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB05350" assertion.
- drugbank:DB05350 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB05350 bio2rdf_vocabulary:identifier "DB05350" assertion.